Drug
Dalpiciclib Isethionate Abiraterone Acetate Prednisone
Dalpiciclib Isethionate Abiraterone Acetate Prednisone: highest development phase Phase 1, developed by Jiangsu Hengrui Medicine. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Jiangsu Hengrui Medicine
Trials
| Drug | Phase | Indication |
|---|---|---|
| dalpiciclib isethionate tablets; abiraterone acetate tablets; prednisone tablets NCT06099990 | Phase 1 | High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC) |
Latest
No recent events.
Follow Dalpiciclib Isethionate Abiraterone Acetate Prednisone on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.